In this report, we describe the risk profile for insulin treatment initiation in real-life conditions in a large population of patients with T2DM attending diabetes centers in Italy with an average follow-up of 42 months (21–67) and according to age and kidney function. Here, INS is linked to type 2 diabetes mellitus.